Frontlight ResearchEarly access
Taking peopleNo phase
Outcome of a Triple Inner Branched Aortic Arch Stentgraft. A Prospective, Multicenter Registry.
Key facts
- Who runs it
- University Hospital Muenster
- Where
- Germany1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 9 Feb 2023
- Expected to end
- 31 Mar 2027
- Type of study
- Observational
- Treatments tested
- Triple inner branched arch stentgraft
- Record updated
- 13 September 2023
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- 18 years or older
- Presence of Aortic arch pathology
- Treatment planned with triple inner branch from Terumo Aortic
- Availability of the patients during the follow up period
- Informing patients about the study and providing written informed consent
Who cannot take part
- Women of childbearing age
- Patients under 18 years
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Outcome of a triple inner branched aortic arch stentgraft. A prospective, mulitcenter registry.
Treatments tested
- Triple inner branched arch stentgraft
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 13 September 2023